News

COSMOS: Simeprevir plus sofosbuvir elicits sustained viral response

Publish date: November 6, 2013

 

FROM THE LIVER MEETING 2013

aault@frontlinemedcom.com

On Twitter @aliciaault

Pages

Recommended Reading

Study identifies preferred approach to managing anemia from HCV treatment
MDedge Internal Medicine
Biologic therapy doesn’t preclude vaccinating psoriasis patients
MDedge Internal Medicine
Single dose of HPV16/18 vaccine appears immunogenic
MDedge Internal Medicine
Risk-based screening misses hepatitis C in many pregnant women
MDedge Internal Medicine
Undetectable viral load cut HCV morbidity, mortality
MDedge Internal Medicine
Twelve percent of boomers are HCV-positive in ED screening study
MDedge Internal Medicine
Study finds interferon-free oral regimen effective, safe in hepatitis C, HIV coinfected patients
MDedge Internal Medicine
Hepatic failure flagged as unexpected boceprevir safety signal in adverse event review
MDedge Internal Medicine
ECHO model cost-effective for HCV
MDedge Internal Medicine
Sofosbuvir and ribavirin combo reduced HCV recurrence post transplant
MDedge Internal Medicine